Skip to content

Combating Opioid Dependence

Combating Opioid Dependence

The opioid epidemic is a hot topic across the United States, along with the alternatives that could alleviate the tragic consequences the epidemic brings. Opioids, also known as narcotics, are strong prescription pain relievers such as oxycodone, hydrocodone and fentanyl. Although illegal, heroin is also considered to be an opioid. Most patients are introduced to these strong narcotics after a major injury or surgery and should only use them on a short-term basis. Unfortunately, this short-term timeline is not always followed, and the patient can become dependent on the pain killers for everyday life.

Understanding Opioid Dependence

Every day, more than 130 people in the United States die from an opioid overdose – including prescription pain relievers, heroin and synthetics. See below for additional facts we’ve uncovered regarding the opioid crisis:

  • Roughly 21-29% of patients prescribed opioids for chronic pain misuse them
  • Between 8-12% develop an opioid use disorder
  • An estimated 4-6% who misuse prescription opioids transition to heroin
  • About 80% of people who use heroin first misused prescription opioids

Ultimately, the opioid epidemic has become a severe national crisis that affects public health as well as social and economic welfare. Not only does the devastating issue carry consequences like an increase in opioid misuse and related overdoses, it’s also a catalyst for neonatal abstinence syndrome due to opioid use during pregnancy. As more opioid users turn to something stronger, like heroin, an increase in injection drug use follows, contributing to the spread of infectious diseases such as HIV and hepatitis C.

A Better Option

Both prescription opioids and cannabis have the same primary use: analgesia – the inability to feel pain. Currently, up to 90% of patients in state-level medical cannabis registries list chronic pain as their qualifying condition. According to a review conducted by the National Academies of Science and Medicine, when given access to cannabis, patients currently using opioids for chronic pain decreased their use by 40-60% and reported that they prefer cannabis rather than opioids. Patients also reported fewer side effects with cannabis and a better quality of life compared to opioids. 

Although there is minimal clinical literature that supports the use of cannabis as a treatment for acute pain, there is a long-standing body of pre-clinical evidence that demonstrates the effectiveness of cannabinoids in providing a pain-free life in drug-naïve animals.

“The mechanisms of cannabinoid antinociception are remarkably similar to those of opioid analgesics. Both the CB1 and MOR are G-protein coupled receptors, and agonist-initiated disinhibition of GABA release in the descending pain pathway is just one example of overlapping antinociceptive mechanisms between these drugs.” -NCBI.gov

The evidence we do have that supports the role of cannabis in acute, nonsevere pain management could lead to a substantial reduction in opioid prescription use. This increase in medical marijuana use for treating acute pain could eliminate patients being exposed to the risks of opioid dose escalation and physical dependence. We still have a long way to go, but the potential impact of this therapy definitely warrants further exploration of the efficacy of cannabis for pain relief and eliminating opioid dependence.

Interested in learning more about medical cannabis efficacies for opioid dependence or other qualifying conditions? Join Arfinn Med for FREE today to access HIPAA compliant peer-to-peer data on medical marijuana treatment efficacies, discuss treatment plans with other licensed physicians and stay up-to-date on all of the latest industry findings.

Sources: https://medlineplus.gov/healthtopics/opioidabuseandaddiction_b.html?utm_expid=.YDctbaKlRwemM6rjn-4YCA.2&utm_referrer=https%3A%2F%2Fwww.google.com%2F

https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135562/

Stories you may be interested in

Alternative Mississippi medical marijuana program barely wins approval from Senate

JACKSON • Legislation that would create a new medical marijuana program in Mississippi if the voter-approved Initiative 65 is overturned in court cleared the state Senate on the second try last week early on Friday morning. Senate Bill 2765, the Mississippi Medical Cannabis Act, failed by a single vote Thursday evening. But six hours later, after…
Read More

Aching for a Better Alternative?

To close out Arthritis Awareness Month, we’re highlighting how medical marijuana may be a beneficial alternative treatment for this painful and debilitating disease. With over 31 million Americans suffering from various types of arthritis, the condition stands as the leading disability throughout the U.S. As many may know, arthritis is most common among the middle-aged…
Read More

Finally, Georgia can grow medical marijuana. Here’s what you need to know.

Four years ago, Governor Nathan Deal signed into law Haleigh’s Hope Act, which made low-THC cannabis oil legal to use by those with certain medical conditions. However, as it was still against the law to buy or grow marijuana in the state, it was virtually impossible to obtain the oil in Georgia. Patients were forced…
Read More

New Feature: Text Message Treatment Updates

New to the Arfinn Med portal comes the ability to receive real time updates from patients via text messaging. This new addition will allow physicians to stay up to date on current patient efficacies as well as streamline the data collection process. Through the new text messaging function, physicians are able to send patients automated…
Read More

Customize Your Patient Notes with Arfinn Med

Joining the text messaging update, the Arfinn Med portal now presents the ability to create note taking templates. This innovative addition will allow physicians to streamline the data and information that they are collecting from patients, resulting in their cases staying aligned and concise. Additionally, through this function, physicians will be able to pick and…
Read More

Florida’s largest cannabis company makes a deal to carry edible marijuana products

TALLAHASSEE The state’s first and largest medical marijuana provider, Trulieve, signed an exclusive deal to bring high-end edible marijuana products to Florida, the company announced Wednesday. Binske, the Colorado-based company, began operations just two years ago, markets “an experience” through their top-shelf products. Florida’s 162,000 registered patients will soon be able to buy and medicate…
Read More

Leave a Comment

You must be logged in to post a comment.